compounded semaglutide lawsuit FDA sued over 'reckless and arbitrary' decision compounded semaglutide lawsuit news today

Clinical trials back both semaglutide and tirzepatide for weight loss

GLP-1 drugs may have a beneficial effect across many types of cancer By Nancy Lapid June 3 (Reuters) - A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer

*In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)

The simple answer after the extensive research is Yes , semaglutide is FDA-approved for weight management in individuals without diabetes

And it was just like I'm at a gym, any gym and I'm just on a stationary cycle listening to a podcast, doing something, which is fine if that's your groove

Cha YS, Sachan DS (1995)